Variations in the promoter region of the apolipoprotein A-1 gene influence plasma lipoprotein(a) levels in asian indian neonates from singapore

Pediatric Research

Volumn 49, Issue 4, 2001, Pages 514-518

  Heng, Chew Kiat ^a   Low, Poh Sim ^a   Saha, Nilmani ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b Biology and Environment   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; LIPOPROTEIN A;

ARTICLE; ASIAN; DNA POLYMORPHISM; ETHNIC GROUP; FEMALE; GENDER; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; INDIAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; PROMOTER REGION; SINGAPORE; UMBILICAL CORD BLOOD;

APOLIPOPROTEIN A-I; BASE SEQUENCE; DNA PRIMERS; HUMANS; INFANT, NEWBORN; LIPOPROTEIN(A); POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SINGAPORE; VARIATION (GENETICS);

EID: 0035070714     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/00006450-200104000-00013     Document Type: Article

References (46)

1. Wilson PW, Anderson KM, Harris T, Kannel WB, Castelli WP 1994 Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J Gerontol 49: M252-M257
2. Breslow JL, Eisenberg S, Brinton EA 1993 Metabolic determinants of low HDL-C levels. (Review). Ann N Y Acad Sci 1993 676: 157-162
3. Ordovas JM, Schaefer EJ, Salem D, Ward RH, Glueck CJ, Vergani PW, Wilson F, Karathanasis SK 1986 Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinaemia. N Engl J Med 314: 671-677
4. Wile DB, Barbir M, Gallagher J, Myant NB, Ritchie CD, Thompson GR, Humphries SE 1989 Apolipoprotein A-I gene polymorphisms: frequency in patients with coronary artery disease and healthy controls and association with serum apo A-I and HDL-cholesterol concentration. Atherosclerosis 78: 9-18
5. Moll PP, Michels W, Weidman WH, Kottke BA 1989 Genetic determination of plasma apolipoprotein A-I in a population-based sample. Am J Hum Genet 44: 124-139
6. Prenger VL, Beaty TH, Kwiterovich PO 1992 Genetic determination of high density lipoprotein-cholesterol and apolipoprotein A-I plasma levels in a family study of cardiac catheterization patients. Am J Hum Genet 51: 1047-1057
7. Hasstedt SJ, Albers JJ, Cheung MC, Jorde LB, Wilson DE, Edwards CQ, Cannon WN, Ash KO, Williams RR 1984 The inheritance of high density lipoprotein cholesterol and apolipoproteins A-I and A-II. Atherosclerosis 85: 21-29
8. Borecki IB, Rao DC, Third JL, Laskarzewski PM, Glueck CJ 1986 A major gene for primary hyperalphalipoproteinemia. Am J Hum Genet 38: 373-381
9. Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, van Dam M, Yu L, Brewer C, Collins JA, Molhuizen HOF, Loubser O, Ouelette BFF, Fichter K, Ashbourne-Excoffon KJD, Sensen CW, Scherer S, Mott S, Denis M, Martindale D, Frohlich J, Morgan K, Koop B, Pimstone S, Kastelein JJP, Genest J Jr, Hayden MR 1999 Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 22: 336-345
10. Bodzioch M, Orso E, Klucken J, Langmann T, Böttcher A, Diederich W, Drobnik W, Barlage S, Büchler C, Porsch-özcürümez M, Kaminski WE, Hahmann HW, Oette K, Rothe G, Aslanidis C, Lackner KJ, Schmitz G 1999 The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 22: 347-351
11. Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette JC, Deleuze JF, Brewer HB, Duverger N, Denèfle P, Assmann G 1999 Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 22: 352-355
12. Karathanasis SK 1985 Apolipoprotein multigene family: tandem organization of human apolipoprotein A-I, C-III and A-IV genes. Proc Natl Acad Sci U S A 82: 6374-6378
13. Bruns GA, Karathanasis SK, Breslow JL 1984 Human apolipoprotein A-I C-III gene complex is located in chromosome 11. Arteriosclerosis 4: 79-83
14. Jeenah M, Kessling A, Miller N, Humphries SE 1990 G to A substitution in the promoter region of the apolipoprotein A-I gene is associated with elevated A-I and high density lipoprotein cholesterol concentrations. Mol Biol Med 7: 233-241
15. Pagani F, Sidoli A, Giudici GA, Barenghi L, Vergani C, Baralle FE 1990 Human apolipoprotein A-I gene promoter polymorphism: association with hyperalphalipoproteinemia. J Lipid Res 31: 1371-1377
16. Sigurdsson G Jr, Gudnason V, Sigurdsson G, Humphries SE 1992 Interaction between a polymorphism of the apo A-I promoter region and smoking determines plasma levels of HDL and apo A-I. Arterioscler Thromb 12: 1017-1022
17. Saha N, Tay JSH, Low PS, Humphries SE 1994 Guanidine to adenine (G/A) substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI levels in Chinese non-smokers. Genet Epidemiol 11: 255-264
18. Xu C-F, Angelico F, Del Ben M, Humphries SE 1993 Role of genetic variation at the apoA-I-C-III-A-IV gene cluster in determining plasma apo A-I levels in boys and girls. Genet Epidemiol 10: 113-122
19. Humphries S, Gudnason V, Paul-Hayse H, Saha N, Rossenneu M 1993 Identification of common genetic polymorphism that determine plasma levels of apo A-I and HDL-C. In: Sirtori CR, Franceschini G, Brewer BH Jr (eds) Human Apolipoprotein Mutants III: Diagnosis and Treatment. Springer-Verlag, Berlin, pp 247-260
20. Talmud PJ, Ye S, Humphries, EARS Group 1994 Polymorphism in the promoter region of the apolipoprotein AI gene associated with differences in apolipoprotein AI levels. The European Atherosclerosis Research Study. Genet Epidemiol 11:265-280
21. Paul-Hayase H, Rosseneu M, Robinson D, van Bervliet JP, Deslypere JP, Humphries SE 1992 Polymorphisms in the apolipoprotein (apo) A-I-CIII-AIV gene cluster: detection of genetic variation determining plasma apo A-I, apo C-III and apo A-IV concentrations. Hum Genet 88: 439-446
22. Smith JD, Brinton EA, Breslow JL 1992 Polymorphism in the human apolipoprotein A-I gene promoter region. Association of the minor allele with decreased production rate in vivo and promoter activity in vitro. J Clin Invest 89: 1796-1800
23. Needham EWS, Mattu RK, Rees A, Stocks J, Galton DJ 1994 A polymorphism in the human apolipoprotein AI promoter region. A study in hypertriglyceridaemic patients. Hum Hered 44: 94-99
24. Barre DE, Guerra R, Vertraete R, Wang Z, Grundy SM, Cohen JC 1994 Genetic analysis of a polymorphism in the human apolipoprotein A-I gene promoter: effect on plasma HDL-cholesterol levels. J Lipid Res 35: 1292-1296
25. Tuteja R, Tuteja N, Melo C, Casari G, Baralle FE 1992 Transcription efficiency of human apolipoprotein A-I promoter varies with naturally occurring A to G transition. FEBS Lett 304: 98-101
26. Angotti E, Mele E, Costanzo F, Avvedimento EV 1994 A polymorphism (G→A transition) in the -78 position of the apolipoprotein A-I promoter increases transcription efficiency. J Biol Chem 269: 17371-17374
27. Juo SH, Wyszynski DF, Beaty TH, Huang HY, Bailey-Wilson JE 1999 Mild association between the A/G polymorphism in the promoter of the apolipoprotein A-I gene and apolipoprotein A-1 levels: a meta-analysis. Am J Med Genet 82: 235-241
28. Wang XL, Badenhop R, Humphrey K, Wilcken DEL 1994 C to T and G to A transitions are responsible for loss of a Msp l restriction site in the 5&#x2032-region of the human apolipoprotein AI gene. Hum Genet 95: 473-475
29. Wang XL, Badenhop R, Humphrey R, Wilcken DEL 1996 New Msp I polymorphism at +83 bp of the human apolipoprotein AI gene: association with increased circulating high density lipoprotein cholesterol levels. Genet Epidemiol 13: 1-10
30. Kamboh MI, Aston CE, Nestlerode CM, McAllister AE, Hamman RF 1996 Haplotype analysis of two APOA1/ Msp I polymorphisms in relation to plasma levels of apo A-I and HDL-cholesterol. Atherosclerosis 127: 255-262
31. Wang XL, Liu SX, McCredie RM, Wilcken DEL 1996 Polymorphisms at the 5&#x2032 end of the apolipoprotein AI gene and severity of coronary artery disease. J Clin Invest 98: 372-377
32. Reguero JR, Cubero GI, Batalla A, Alvarez V, Hevia S, Cortina A, Coto E 1998 Apolipoprotein A1 gene polymorphisms and risk of early coronary artery disease. Cardiology 90: 231-235
33. Low PS, Saha N, Tay JSH, Hong S 1996 Ethnic variation of cord plasma apolipoprotein levels in relation to coronary risk level: a study in three ethnic groups of Singapore. Acta Paediatr 85: 1476-1482
34. Low PS, Heng CK, Saha N, Tay JSH 1996 Racial variation of cord plasma lipoprotein(a) levels in relation to coronary risk level: a study in three ethnic groups of Singapore. Ped Res 40: 718-722
35. Parzer S, Mannhalter CA 1991 Rapid method of the isolation of genomic DNA from citrated whole blood. Biochem J 273: 229-231
36. Chakravarti A, Buetow KH, Antonarakis SE, Waber PG, Boehm CD, Kazazian HH 1984 Nonuniform recombination within the human β-globin gene cluster. Am J Hum Genet 36: 1239-1258
37. Lopez-Miranda J, Ordovas JM, Espino A, Marin C, Salas J, Lopez-Seura F, Jimenez-Pereperez J, Perez-Jimerez F 1994 Influence of mutation in human apolipoprotein A-1 gene promoter on plasma LDL cholesterol response to dietary fat. Lancet 343: 1246-1249
38. Kamboh MI, Bunker CH, Aston CE, Nestlerode CS, McAllister AE, Ukoli FA 1999 Genetic association of five apolipoprotein polymorphisms with serum lipoprotein-lipid levels in African blacks. Genet Epidemiol 16: 205-222
39. Minnich A, DeLangavant G, Lavigne J, Roederer G, Lussier-Cacan S, Davignon J 1995 G→A substitution at position -75 of the apolipoprotein A-I gene promoter-evidence against a direct effect on HDL cholesterol levels. Arterioscler Thromb Vasc Biol 15: 1740-1745
40. Albers JJ, Taggart HM, Applebaum-Bowden D, Haffner S, Chesnut CH, III Hazzard WR 1984 Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and Lp(a) lipoprotein with the anabolic steroid stanozolol. Biochim Biophy Acta 795: 293-296
41. Soma M, Fumagalli R, Paoletti R, Meschia M, Maini MC, Crosignani P, Ghanem K, Gaubatz J, Morrisett JD 1991 Plasma Lp(a) concentration after oestrogen and progestagen in postmenopausal women. Lancet 337: 612
42. Denti L, Pasolini G, Ablondi F, Valenti G 1994 Correlation between plasma lipoprotein Lp(a) and sex hormone concentrations: a cross-sectional study in healthy males. Horm Metab Res 26: 602-608
43. Haffner SM, Mykkanen L, Gruber KK, Rainwater DL, Laakso M 1994 Lack of association between sex hormones and Lp(a) concentrations in American and Finnish men. Arterioscler Thromb 14: 19-24
44. Liu AC, Lawn RM, Verstuyft JG, Rubin EM 1994 Human apolipoprotein A-I prevents atherosclerosis associated with apolipoprotein(a) in transgenic mice. J Lipid Res 35: 2263-2267
45. Low PS, Heng CK, Quek SC, Saha N, MI Kamboh 1999 Significant influence of the +93 C/T polymorphism in the apolipoprotein(a) gene on Lp(a) concentrations in the Asian Indian neonates from Singapore. Am J Hum Genet 65:A210
46. Scanu AM 1997 From big A to small (a) or vice versa. Circulation 96: 1-F